HON vs MRK: Which Is the Better Buy?
Side-by-side comparison of Honeywell International Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
Honeywell International Inc. · Industrials
$222.25
-5.5% upside to fair value
Grade D
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
HON has more upside to fair value
(-5.5%).
HON trades at a lower forward P/E
(15.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
HON |
MRK |
| Current Price |
$222.25 |
$113.87 |
| Fair Value Estimate |
$210.05 |
$100.14 |
| Upside to Fair Value |
-5.5%
|
-12.1%
|
| Market Cap |
$70.4B |
$281.2B |
| Forward P/E |
15.7x
|
32.0x
|
| EV / EBITDA |
13.1x
|
17.3x
|
| Price / Sales |
1.9x
|
4.3x
|
| Price / FCF |
17.1x
|
19.9x
|
| Revenue Growth YoY |
-6.9%
|
+4.3%
|
| Gross Margin |
36.9%
|
75.9%
|
| Operating Margin |
14.9%
|
27.6%
|
| Return on Equity |
23.6%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.84%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Honeywell International Inc. operates as a diversified industrial conglomerate with a strong presence in multiple sectors including aerospace, building technologies, and performance materials. The company demonstrates high business quality with a durable competitive moat supported by strong margins, a 23.6% return on equity, and solid free cash flow generation of $16.78 per share. However, recent…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
HON |
MRK |
| Zone Low |
$157.54 |
$75.11 |
| Zone High |
$178.54 |
$85.12 |
| In Buy Zone? |
No
|
No
|